Back to Journals » Infection and Drug Resistance » Volume 11

Plasmodium knowlesi malaria: current research perspectives

Authors Amir A, Cheong FW, de Silva JR, Liew JWK, Lau YL

Received 26 February 2018

Accepted for publication 22 May 2018

Published 10 August 2018 Volume 2018:11 Pages 1145—1155

DOI https://doi.org/10.2147/IDR.S148664

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 4

Editor who approved publication: Professor Suresh Antony


Amirah Amir, Fei Wen Cheong, Jeremy Ryan de Silva, Jonathan Wee Kent Liew, Yee Ling Lau

Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Abstract: Originally known to cause simian malaria, Plasmodium knowlesi is now known as the fifth human malaria species. Since the publishing of a report that largely focused on human knowlesi cases in Sarawak in 2004, many more human cases have been reported in nearly all of the countries in Southeast Asia and in travelers returning from these countries. The zoonotic nature of this infection hinders malaria elimination efforts. In order to grasp the current perspective of knowlesi malaria, this literature review explores the different aspects of the disease including risk factors, diagnosis, treatment, and molecular and functional studies. Current studies do not provide sufficient data for an effective control program. Therefore, future direction for knowlesi research is highlighted here with a final aim of controlling, if not eliminating, the parasite.

Keywords: zoonosis, epidemiology, diagnosis, treatment, molecular, functional studies

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]